SMAD3 and neoplasm: It is known that TGF-β/Smad3 signaling in leukocytes promotes tumor growth by suppressing antitumor cytotoxicity by CD8 + T cells10 and NK cells9, and by promoting the transition of tumor-associated macrophages into fibroblasts within the TME14.